Stories about: technology transfer

For biomedicine startups, the road to commercialization is paved with mentors and winds through Boston

the road for biomedicine startups

Marina Freytsis, PhD, supports the Technology and Innovation Development Office (TIDO) at Boston Children’s Hospital in seeking industry partnerships for Boston Children’s technologies and intellectual property.

Last week, Boston Children’s Hospital’s Technology and Innovation Development Office (TIDO) had the privilege of hosting a Boston Biomedical Innovation Center (B-BIC) panel discussion on the path from academia to entrepreneurship. We heard from Jeffrey Arnold (an angel investor), Jonathan Thon (an academic-turned-CEO) and Pamela Silver (an entrepreneurial professor).

My top five takeaways for budding entrepreneurs:

Read Full Story | Leave a Comment

Licensing: It’s not just the money

(Photo: iChaz/Flickr)

An article popped up in my Google alerts that gave me some excitement.  A survey from the Association of University Technology Managers, reported in Mass High Tech, placed Children’s Hospital Boston fifth in licensing income among all U.S. hospitals. We were ranked just below the Mayo Clinic, which has more than double the research funding of Children’s. Massachusetts General Hospital was second on the list and Brigham and Women’s was eighth.*

I don’t often get to see quick financial results from my work (I’m the marketing and communications specialist in Children’s Technology and Innovation Development Office (TIDO), which licenses the Hospital’s technologies). But what I do get to see regularly is just as important to our mission: small advances that barely impact the hospital’s bottom line but have a large significance to our patients.

Read Full Story | 2 Comments | Leave a Comment

Biopharm America 2010, Day 3: Giving tech transfer a seat at the table

Arm Wrestling

First let me start out by saying that we are no longer ‘Tech Transfer.’ According to Children’s Hospital Boston’s Technology and Innovation Development Office (TIDO) Director, Erik Halvorsen who was a panelist at an event called  “From Idea to Company: Fundamental Building Blocks,” at the BioPharm America conference, the term ‘Tech Transfer’ is like the band Nirvana, which was popular in the nineties but has since lost its appeal among contemporary music fans.

Read Full Story | 2 Comments | Leave a Comment